All Stories

Fierce Biotech Layoff Tracker 2025: BioNTech lays off 63 as it ends CAR-T development in testicular cancer

As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.

Jun 18, 2025 - 19:00
 0
Fierce Biotech Layoff Tracker 2025: BioNTech lays off 63 as it ends CAR-T development in testicular cancer
As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.
Read More

Tags:

Previous Article

Bavarian Nordic's $160M FDA speedy review voucher sale shows prices keep rising ...

Next Article

FDA Offers Speedier Approvals to Drug Companies Aligning With 'National Priorities'

Related Posts

Merck KGaA shares phase 3 rare tumor data ahead of showdown with Daiichi and Ono

Merck KGaA shares phase 3 rare tumor data ahead of show...

May 28, 2025  0

Erasca enters another era, seeks partner for phase 3 ex-Novartis asset

Erasca enters another era, seeks partner for phase 3 ex...

May 14, 2025  0

Keros culls PAH asset, prompting layoffs for 70 workers

Keros culls PAH asset, prompting layoffs for 70 workers

May 29, 2025  0